Cao, Y., Shi, . F. ., Li, Y. ., Wei, X. ., Yi, . H. ., & Han, S. . (2024). Cost-effectiveness analysis of the combination of low-dose nivolumab with triple metronomic chemotherapy for advanced head and neck squamous cell carcinoma in China. Health Decision, 2(S1). https://doi.org/10.54844/hd.2024.0008